Systolic blood pressure (SBP) of the carvedilol group and the ivabradine group slightly increased compared to the myocarditis group on days 7 and 14, but this effect did not reach statistical significance, and SBP of the ivabradine group did not differ compared to the carvedilol group.
← all excerpts
Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
2
—
—
The sentences
The primary composite endpoint of cardiovascular death or hospital admission for worsening heart failure was significantly reduced, largely due to a highly significant reduction in hospitalization from heart failure.